Escalating burden and mortality of carbapenem-resistant Klebsiella pneumoniae species complex infections in Bangladeshi infants
Authors:
Open Access
- 23 June 2026
- journal article
- Published by Springer Nature in npj Antimicrobials and Resistance
- Vol. 4 (1)
Abstract
Klebsiella pneumoniae infections in young infants are an escalating threat in low- and middle-income countries, yet robust longitudinal data integrating hospital burden, clinical outcomes, antimicrobial resistance, and genomics remains scarce. We performed an 18-year (2004–2021) prospective, multicenter genomic epidemiology study across four hospitals in Bangladesh. Among 122,353 enrolled children from whom blood and/or cerebrospinal fluid cultures were performed, 1600 (1.3%) yielded culture-confirmed Klebsiella pneumoniae species complex (KpSC) isolates. Positivity increased from 16 per 1000 cases tested in 2004 to 37 per 1000 in 2021. Hospital case-fatality rate (CFR) rose from 21.4% to 51.4% during the study, paralleling the emergence and expansion of carbapenem resistance, first detected in 2008 and reaching 81% of isolates by 2021. Neonates accounted for 80.5% of infections and experienced a CFR of 40.8%. Whole-genome sequencing of 599 representative isolates revealed four KpSC species, 145 sequence types, and 92 capsular alleles. Global high-risk clones ST11, ST16, and ST147 harbouring NDM-type carbapenemases dominated recent cases. These findings document the increasing resistance and mortality associated with KpSC infections amongst neonates in Bangladesh, underscoring the urgent need for strengthened infection prevention and control, equitable access to effective combination therapies, and vaccine-based preventative strategies.Keywords
Funding Information
- Bill and Melinda Gates Foundation (INV023821)
This publication has 42 references indexed in Scilit:
- Vaccine value profile for Klebsiella pneumoniaeVaccine, 2024
- Neonatal sepsis and mortality in low-income and middle-income countries from a facility-based birth cohort: an international multisite prospective observational studyThe Lancet Global Health, 2022
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisThe Lancet, 2022
- Hot weather and heat extremes: health risksThe Lancet, 2021
- Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort studyThe Lancet Infectious Diseases, 2019
- Klebsiella pneumoniae capsule polysaccharide as a target for therapeutics and vaccinesComputational and Structural Biotechnology Journal, 2019
- Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteriaCurrent Opinion in Microbiology, 2018
- Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort studyThe Lancet, 2018
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemasesThe Lancet Infectious Diseases, 2013
- Hospital-acquired neonatal infections in developing countriesThe Lancet, 2005